Name: UMIN ID:
Unique ID issued by UMIN | C000000271 |
---|---|
Receipt number | R000000342 |
Scientific Title | A phase II study of cisplatin with TS-1 for patients with cancer of primary unknown |
Date of disclosure of the study information | 2005/10/31 |
Last modified on | 2018/03/04 21:56:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/10/31 11:51:33 | ||
2 | Update | 2010/05/01 08:48:08 | Organization Organization Address Address TEL Organization Organization Address Address TEL Email1 Organization2 Address2 Tel2 Email2 |
|
3 | Update | 2010/05/01 08:49:08 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
4 | Update | 2010/11/01 09:16:12 | Address |
|
5 | Update | 2011/04/30 10:40:46 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2012/10/31 14:41:23 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2018/03/04 21:50:23 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
8 | Update | 2018/03/04 21:52:42 | Email Name of primary person or sponsor Organization |
|
9 | Update | 2018/03/04 21:56:39 | Recruitment status Publication of results |